|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 975 F Street NW Suite 500 |
Address2 | |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 40032282-87
|
||||||||
|
6. House ID# 399140004
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Richard J Tarplin, Manager |
Date | 10/23/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Implementation of the Medicare Improvements for Patients and Providers Act of 2008, reimbursement for home oxygen therapy.
CMS regulations concerning the DMEPOS Competitive Bidding program, inhalation drugs and sleep disorder therapies.
Public Law 111-148, the Patient Protection and Affordable Care Act of 2009 - implementation issues related to reimbursement process and payment levels for Medicare home oxygen benefit.
Regulatory issues related to Medicare inhalation drug Therapies and oxygen reimbursement, provider enrollment standards, DME Competitive Bidding, CPAP coverage & reimbursement, program integrity.
P.L. 112-240, the American Taxpayer Relief Act of 2012 - Potential offsets to nullify Medicare physician payment cuts related to respiratory therapy services.
H. Con. Res. 25, Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023; and S.Con.Res. 8, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023 - Medicare reimbursement for inhalation theray and home oxygen services.
S. 388, American Family Economic Protection Act of 2013 - sequestration issues affecting Medicare reimbursement for inhalation theray and home oxygen services.
S.2000 - The SGR Repeal and Medicare Provider Payment Modernization Act of 2014 - Medicare DME reimbursement issues.
H.R.4015 -The SGR Repeal and Medicare Provider Payment Modernization Act of 2014 - Medicare DME reimbursement issues.
Public Law 113-93 - The Protecting Access to Medicare Act of 2014 - Medicare DME reimbursement issues.
Participated in discussions with HHS/CMS staff and congressional staff on audit activities and settlement of appeals.
Participated in discussions with congressional and HHS/CMS staff about prior authorization and prospective payment reforms affecting DME suppliers.
Participated in discussions with HHS/CMS staff concerning Medicare reimbursement for home based International Normalized Ratio (INR) monitoring services.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Tarplin |
|
Assistant Secretary for Legislation/HHS; Principal |
|
continued |
Tarplin |
|
Deputy Assistant Secretary for Legislation/HHS; |
|
continued |
Tarplin |
|
Staff Director, Senate Subcommittee on Children |
|
continued |
Tarplin |
|
and Families. |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |